General overgrowth in the fragile X syndrome: variability in the phenotypic expression of the FMR1 gene mutation.
de Vries
B B
BB
Department of Clinical Genetics, University Hospital Dijkzigt, Rotterdam, The Netherlands.
Robinson
H
H
Stolte-Dijkstra
I
I
Tjon Pian Gi
C V
CV
Dijkstra
P F
PF
van Doorn
J
J
Halley
D J
DJ
Oostra
B A
BA
Turner
G
G
Niermeijer
M F
MF
D000328:Adult; D002675:Child, Preschool; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000150:complications / Q000235:genetics* / Q000503:physiopathology; D006130:Growth Disorders / Q000209:etiology / Q000235:genetics* / Q000503:physiopathology; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008297:Male; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D016601:RNA-Binding Proteins
D051860:Fragile X Messenger Ribonucleoprotein 1; D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human